| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From INSERM, Nutriomique, U872 (team 7), Paris, France (NN, KC, MG-M, and SWR); AP-H, Hôtel-Dieu Hospital, Departments of Diabetes and Nutrition, Paris, France (MK, GS, VP, GS, KC, and SWR); University Pierre and Marie Curie-Paris 6, Center of Research of Cordeliers, Paris, France (NN, KC, MG-M, and SWR); the Center of Research on Human Nutrition (CRNH-Ile de France), Paris, France (KC, MG-M, and SWR); INSERM, U870-INRA U1235, Faculty of Medicine Rene Laennec, Lyon, France (EM, SR, and HV); and INRA-INA-PG, UMR 914, Paris, France (AQ-B)
Background: Information is lacking on the potential effect of n–3 polyunsaturated fatty acids (PUFAs) on the adipose tissue of patients with type 2 diabetes.
Objective: We evaluated whether n–3 PUFAs have additional effects on adiposity, insulin sensitivity, adipose tissue function (production of adipokines and inflammatory and atherogenic factors), and gene expression in type 2 diabetes.
Design: Twenty-seven women with type 2 diabetes without hypertriglyceridemia were randomly allocated in a double-blind parallel design to 2 mo of 3 g/d of either fish oil (1.8 g n–3 PUFAs) or placebo (paraffin oil).
Results: Although body weight and energy intake measured by use of a food diary were unchanged, total fat mass (P < 0.019) and subcutaneous adipocyte diameter (P < 0.0018) were lower in the fish oil group than in the placebo group. Insulin sensitivity was not significantly different between the 2 groups (measured by homeostasis model assessment in all patients and by euglycemic-hyperinsulinemic clamp in a subgroup of 5 patients per group). By contrast, atherogenic risk factors, including plasma triacylglycerol (P < 0.03), the ratio of triacylglycerol to HDL cholesterol (atherogenic index, P < 0.03), and plasma plasminogen activator inhibitor-1 (P < 0.01), were lower in the fish oil group than in the placebo group. In addition, a subset of inflammation-related genes was reduced in subcutaneous adipose tissue after the fish oil, but not the placebo, treatment.
Conclusions: A moderate dose of n–3 PUFAs for 2 mo reduced adiposity and atherogenic markers without deterioration of insulin sensitivity in subjects with type 2 diabetes. Some adipose tissue inflammation-related genes were also reduced. These beneficial effects could be linked to morphologic and inflammatory changes in adipose tissue. This trial was registered at clinicaltrials.gov as NCT0037.
Key Words: Adiposity • fish oil • type 2 diabetes • women • adipocyte size • PAI-1 • atherogenic index • adipose tissue inflammation-related genes
This article has been cited by other articles:
|
|
 |
|
  V. Saraswathi, J. D. Morrow, and A. H. Hasty Dietary Fish Oil Exerts Hypolipidemic Effects in Lean and Insulin Sensitizing Effects in Obese LDLR-/- Mice J. Nutr., December 1, 2009; 139(12): 2380 - 2386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Batetta, M. Griinari, G. Carta, E. Murru, A. Ligresti, L. Cordeddu, E. Giordano, F. Sanna, T. Bisogno, S. Uda, et al. Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats J. Nutr., August 1, 2009; 139(8): 1495 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Asserhoj, S. Nehammer, J. Matthiessen, K. F. Michaelsen, and L. Lauritzen Maternal Fish Oil Supplementation during Lactation May Adversely Affect Long-Term Blood Pressure, Energy Intake, and Physical Activity of 7-Year-Old Boys J. Nutr., February 1, 2009; 139(2): 298 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B M Yashodhara, S Umakanth, J M Pappachan, S K Bhat, R Kamath, and B H Choo Omega-3 fatty acids: a comprehensive review of their role in health and disease Postgrad. Med. J., February 1, 2009; 85(1000): 84 - 90. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
